Solid growth across divisions for Baxter
This article was originally published in Scrip
Executive Summary
Baxter International posted solid fourth-quarter results, with worldwide group revenue rising 3% to $3.59 billion. The firm's medical products division grew 3% to $2.01 billion, while sales in its other division, bioscience, also went up 3% to $1.58 billion.